Your browser doesn't support javascript.
loading
Editorial Expression of Concern: Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function.
Serini, Guido; Valdembri, Donatella; Zanivan, Sara; Morterra, Giulia; Burkhardt, Constanze; Caccavari, Francesca; Zammataro, Luca; Primo, Luca; Tamagnone, Luca; Logan, Malcolm; Tessier-Lavigne, Marc; Taniguchi, Masahiko; Püschel, Andreas W; Bussolino, Federico.
Afiliação
  • Serini G; Division of Molecular Angiogenesis, IRCC, Institute for Cancer Research and Treatment, and Department of Oncological Sciences, University of Torino School of Medicine, Candiolo (TO), Italy. guido.serini@ircc.it.
  • Valdembri D; Division of Molecular Angiogenesis, IRCC, Institute for Cancer Research and Treatment, and Department of Oncological Sciences, University of Torino School of Medicine, Candiolo (TO), Italy.
  • Zanivan S; Division of Molecular Angiogenesis, IRCC, Institute for Cancer Research and Treatment, and Department of Oncological Sciences, University of Torino School of Medicine, Candiolo (TO), Italy.
  • Morterra G; Division of Molecular Angiogenesis, IRCC, Institute for Cancer Research and Treatment, and Department of Oncological Sciences, University of Torino School of Medicine, Candiolo (TO), Italy.
  • Burkhardt C; Abt. Molekularbiologie Institut für Allgemeine Zoologie und Genetik, Westfälische Wilhelms-Universität, Münster, Germany.
  • Caccavari F; Division of Molecular Angiogenesis, IRCC, Institute for Cancer Research and Treatment, and Department of Oncological Sciences, University of Torino School of Medicine, Candiolo (TO), Italy.
  • Zammataro L; Division of Molecular Angiogenesis, IRCC, Institute for Cancer Research and Treatment, and Department of Oncological Sciences, University of Torino School of Medicine, Candiolo (TO), Italy.
  • Primo L; Division of Molecular Angiogenesis, IRCC, Institute for Cancer Research and Treatment, and Department of Oncological Sciences, University of Torino School of Medicine, Candiolo (TO), Italy.
  • Tamagnone L; Division of Molecular Oncology, IRCC, Institute for Cancer Research and Treatment, and Department of Oncological Sciences, University of Torino School of Medicine, Candiolo (TO), Italy.
  • Logan M; Division of Developmental Biology, National Institute for Medical Research, London, UK.
  • Tessier-Lavigne M; Department of Biological Sciences, Howard Hughes Medical Institute, Stanford University, Stanford, California, USA.
  • Taniguchi M; Department of Biochemistry and Molecular Biology, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan.
  • Püschel AW; Abt. Molekularbiologie Institut für Allgemeine Zoologie und Genetik, Westfälische Wilhelms-Universität, Münster, Germany.
  • Bussolino F; Division of Molecular Angiogenesis, IRCC, Institute for Cancer Research and Treatment, and Department of Oncological Sciences, University of Torino School of Medicine, Candiolo (TO), Italy. federico.bussolino@ircc.it.
Nature ; 627(8002): E7, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38383792
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nature Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nature Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália